Table 2.
Demographic and clinical data at detection.
| Characteristics | PB leprosy (1053) | MB leprosy (293) | ||||||
|---|---|---|---|---|---|---|---|---|
| TT done (736) |
Defaulters (271) |
Refused (46) |
Total (1053) |
TT done (195) |
Defaulters (94) |
Refused (4) |
Total (293) |
|
| Mean age (SD) | 34.7 (16.8) |
36.1 (17.1) |
34.8 (17.6) |
35.1 (16.9) |
41.6 (16.9) |
46.4 (17.6) |
48.3 (16.6) |
43.3 (17.2) |
| Female (%) | 52.7 | 62.7 | 65.2 | 35.9 | 42.6 | 50.0 | 38.2 | |
| Median delay in detection (months) | 18 | 12 | 12 | 36 | 36 | 42 | 36 | |
| Mean (SD) number of skin lesions | 1.83 (1.08) |
1.79 (1.04) |
1.63 (0.88) |
13.5 (17.4) |
14.6 (18.3) |
12.3 (6.3) |
13.8 (17.5) |
|
| (%) Nerve involvement | 45.7 | 39.9 | 23.9 | 91.3 | 87.2 | 75.0 | 89.8 | |
| Deformity (%) Grade 1 (0.8) Grade 2 (1.0) |
0.7 1.1 |
1.1 0.7 |
0 0 |
— 10.8 |
— 9.6 |
— 0 |
— 10.2 |
|
|
| ||||||||
| (1) ANOVA reflect no mean is significant (NS) | (1) ANOVA reflect no mean is significant | |||||||
| (2) Nerve % involvement, χ 2DF 2 = 10.0. P = 0.007 | (2) Nerve % involvement, NS | |||||||
| (3) Disability NS | (3) Disability NS | |||||||
| (4) Percent female, χ 2DF 2 = 9.8. P = 0.008 | (4) Percent female, NS | |||||||